RNF220 overexpression correlated with poor prognosis in AML, drove an immunosuppressive microenvironment characterized by reduced CD8+ T cells, and inhibited NK activity and M2 polarization of macrophage. This evidence concerns the gene CD8A and acute myeloid leukemia.